Protesters gather in London against the ban of Palestine Action - Global Banking & Finance Review
A large crowd of protesters in London rallies against the ban of Palestine Action, holding flags and placards. This image captures the tension during the protest where over 466 individuals were arrested by police, highlighting the ongoing conflict surrounding Palestine Action and its implications.
Finance

UK's Smith+Nephew keeps annual outlook, plans share buyback as quarterly revenue rises

Published by Global Banking & Finance Review

Posted on May 6, 2026

1 min read

· Last updated: May 6, 2026

Add as preferred source on Google

UK's Smith+Nephew keeps outlook, plans share buyback as quarterly revenue rises

Smith+Nephew's Financial Performance and Strategic Initiatives

Quarterly Revenue Growth

May 6 (Reuters) - Medical products maker Smith+Nephew posted higher first-quarter underlying revenue on Wednesday, helped by strong sports medicine and wound management performance, and kept its annual outlook unchanged while unveiling a $500 million share buyback.

Product Segments Driving Growth

The British company, which makes orthopaedic implants, wound dressings, and other surgical aids, is seeking to accelerate growth following a three-year turnaround to counter margin pressure stemming from inflation and supply‑chain disruptions.

Outlook and Analyst Expectations

The company, which reiterated that growth would be weighed towards the second half of the year, posted revenue of $1.5 billion for the quarter ended March 28, with underlying revenue growth of 3.1%. Analysts were expecting a 3.2% rise in a company-compiled poll.  

(Reporting by Nithyashree R B in Bengaluru; Editing by Sherry Jacob-Phillips and Subhranshu Sahu)

Key Takeaways

  • Q1 underlying revenue rose 3.1% to $1.41 billion, with Sports Medicine & ENT up 2.4% and Advanced Wound Management up 3.8% despite FX and China headwinds (investing.com).
  • Smith+Nephew reaffirmed its full‑year 2025 guidance of ~5% underlying revenue growth and a trading margin of 19–20%, while allowing for a $15–20 million tariff impact (investing.com).
  • The company announced a $500 million share buyback for the second half of 2025, signaling confidence in cash flow and strategic momentum (lse.co.uk).

References

Frequently Asked Questions

What was Smith+Nephew's first-quarter revenue growth?
Smith+Nephew posted a 3.1% rise in underlying revenue for the first quarter.
Did Smith+Nephew change its annual financial outlook?
No, Smith+Nephew kept its annual outlook unchanged.
What is the value of the share buyback announced by Smith+Nephew?
Smith+Nephew announced a $500 million share buyback.
Which segments contributed to Smith+Nephew's revenue increase?
Strong performance in sports medicine and wound management aided revenue growth.
On what date did Smith+Nephew announce these results?
Smith+Nephew announced these results on May 6.

Tags

Related Articles

More from Finance

Explore more articles in the Finance category